Skip to content

Comparison Between Melatonin and Diazepam for Prevention of Recurrent Simple Febrile Seizures

Comparison Between Melatonin and Diazepam for Prevention of Recurrent Simple Febrile Seizures: Randomized Clinical Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03631901
Enrollment
60
Registered
2018-08-15
Start date
2017-04-01
Completion date
2018-09-01
Last updated
2019-09-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Febrile Seizures

Keywords

Melatonin, Diazepam, recurrence, prophylaxis, Febrile convulsions

Brief summary

To evaluate the efficacy of oral melatonin compared to oral diazepam for prevention of recurrent simple febrile seizures.

Detailed description

To evaluate the efficacy of oral melatonin compared to oral diazepam for prevention of recurrence of simple febrile seizures in children aged 6 months to 5 years.

Interventions

Both melatonin and diazepam were given only during the febrile illness.

DRUGoral diazepam

Both melatonin and diazepam were given only during the febrile illness.

Sponsors

Tanta University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
6 Months to 5 Years
Healthy volunteers
No

Inclusion criteria

* Children aged 6 months to 5 yrs . * Simple febrile seizures

Exclusion criteria

* Complex febrile seizures * Child with history of neonatal seizure. * Afebrile seizures. * History of anticonvulsive therapy. * Children suffering from epilepsy. * Children with abnormal EEG. * Children with abnormal neurological examination. * Positive family history of epilepsy.

Design outcomes

Primary

MeasureTime frame
recurrence of febrile seizures during febrile illness6 months

Secondary

MeasureTime frame
side effect of medications reported in children6 months

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026